Michael Hecker

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 29

Top Topics

Liquid Chromatography Tandem Mass Spectrometry

Multiple Sclerosis

Top Venues

International journal of molecular sciences

CNS neuroscience & therapeutics

Journal of personalized medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Andreas Körtge, Anne Breitrück, Sandra Doß, Jacqueline Hofrichter, Sophie-Charlotte Nelz, Horst Krüsemann, Reinhold Wasserkort, Brit Fitzner, Michael Hecker, Steffen Mitzner, Uwe Klaus Zettl
The Utility of Miniaturized Adsorbers in Exploring the Cellular and Molecular Effects of Blood Purification: A Pilot Study with a Focus on Immunoadsorption in Multiple Sclerosis. International journal of molecular sciences 25 (5) (2024)
Andreas Körtge, Anne Breitrück, Sandra Doß, Jacqueline Hofrichter, Sophie-Charlotte Nelz, Horst Krüsemann, Reinhold Wasserkort, Brit Fitzner, Michael Hecker, Steffen Mitzner, Uwe Klaus Zettl
The Utility of Miniaturized Adsorbers in Exploring the Cellular and Molecular Effects of Blood Purification: A Pilot Study with a Focus on Immunoadsorption in Multiple Sclerosis. International journal of molecular sciences 25 (5) (2024)
Andreas Körtge, Anne Breitrück, Sandra Doß, Jacqueline Hofrichter, Sophie-Charlotte Nelz, Horst Krüsemann, Reinhold Wasserkort, Brit Fitzner, Michael Hecker, Steffen Mitzner, Uwe Klaus Zettl
The Utility of Miniaturized Adsorbers in Exploring the Cellular and Molecular Effects of Blood Purification: A Pilot Study with a Focus on Immunoadsorption in Multiple Sclerosis. International journal of molecular sciences 25 (5) (2024)
Michael Hecker, Niklas Frahm, Uwe Klaus Zettl
Update and Application of a Deep Learning Model for the Prediction of Interactions between Drugs Used by Patients with Multiple Sclerosis. Pharmaceutics 16 (1) (2023)
Michael Hecker, Niklas Frahm, Uwe Klaus Zettl
Update and Application of a Deep Learning Model for the Prediction of Interactions between Drugs Used by Patients with Multiple Sclerosis. Pharmaceutics 16 (1) (2023)
Julia Baldt, Niklas Frahm, Michael Hecker, Barbara Streckenbach, Silvan Elias Langhorst, Pegah Mashhadiakbar, Katja Burian, Janina Meißner, Felicita Heidler, Jörg Richter, Uwe Klaus Zettl
Depression and Anxiety in Association with Polypharmacy in Patients with Multiple Sclerosis. Journal of clinical medicine 12 (16) (2023)
Michael Hecker, Brit Fitzner, Nina Boxberger, Elena Putscher, Robby Engelmann, Wendy Bergmann, Michael Müller, Isis Ludwig-Portugall, Margit Schwartz, Stefanie Meister, Ales Dudesek, Alexander Winkelmann, Dirk Koczan, Uwe Klaus Zettl
Transcriptome alterations in peripheral blood B cells of patients with multiple sclerosis receiving immune reconstitution therapy. Journal of neuroinflammation 20 (1) (2023)
Uwe Klaus Zettl, Paulus Stefan Rommer, Orhan Aktas, Torsten Wagner, Joachim Richter, Patrick Oschmann, Lukas Cepek, Birte Elias-Hamp, Klaus Gehring, Andrew Chan, Michael Hecker
Interferon beta-1a sc at 25 years: a mainstay in the treatment of multiple sclerosis over the period of one generation. Expert review of clinical immunology (2023)
Michael Hecker, Niklas Frahm, Uwe Klaus Zettl
Update and Application of a Deep Learning Model for the Prediction of Interactions between Drugs Used by Patients with Multiple Sclerosis. Pharmaceutics 16 (1) (2023)
Franziska Alfen, Elena Putscher, Michael Hecker, Uwe Klaus Zettl, Andreas Hermann, Jan Lukas
Abnormal Pre-mRNA Splicing in Exonic Fabry Disease-Causing GLA Mutations. International journal of molecular sciences 23 (23) (2022)
Franziska Alfen, Elena Putscher, Michael Hecker, Uwe Klaus Zettl, Andreas Hermann, Jan Lukas
Abnormal Pre-mRNA Splicing in Exonic Fabry Disease-Causing GLA Mutations. International journal of molecular sciences 23 (23) (2022)
Paula Bachmann, Niklas Frahm, Jane Louisa Debus, Pegah Mashhadiakbar, Silvan Elias Langhorst, Barbara Streckenbach, Julia Baldt, Felicita Heidler, Michael Hecker, Uwe Klaus Zettl
Prevalence and Severity of Potential Drug-Drug Interactions in Patients with Multiple Sclerosis with and without Polypharmacy. Pharmaceutics 14 (3) (2022)
Silvan Elias Langhorst, Niklas Frahm, Michael Hecker, Pegah Mashhadiakbar, Barbara Streckenbach, Julia Baldt, Felicita Heidler, Uwe Klaus Zettl
Vaccination Coverage against Tetanus, Diphtheria, Pertussis and Poliomyelitis and Validity of Self-Reported Vaccination Status in Patients with Multiple Sclerosis. Journal of personalized medicine 12 (5) (2022)
Franziska Alfen, Elena Putscher, Michael Hecker, Uwe Klaus Zettl, Andreas Hermann, Jan Lukas
Abnormal Pre-mRNA Splicing in Exonic Fabry Disease-Causing GLA Mutations. International journal of molecular sciences 23 (23) (2022)
Franziska Alfen, Elena Putscher, Michael Hecker, Uwe Klaus Zettl, Andreas Hermann, Jan Lukas
Abnormal Pre-mRNA Splicing in Exonic Fabry Disease-Causing GLA Mutations. International journal of molecular sciences 23 (23) (2022)
Franziska Alfen, Elena Putscher, Michael Hecker, Uwe Klaus Zettl, Andreas Hermann, Jan Lukas
Abnormal Pre-mRNA Splicing in Exonic Fabry Disease-Causing GLA Mutations. International journal of molecular sciences 23 (23) (2022)
Elena Putscher, Michael Hecker, Brit Fitzner, Peter Lorenz, Uwe Klaus Zettl
Principles and Practical Considerations for the Analysis of Disease-Associated Alternative Splicing Events Using the Gateway Cloning-Based Minigene Vectors pDESTsplice and pSpliceExpress. International journal of molecular sciences 22 (10) (2021)
Michael Hecker, Jan Bühring, Brit Fitzner, Paulus Stefan Rommer, Uwe Klaus Zettl
Genetic, Environmental and Lifestyle Determinants of Accelerated Telomere Attrition as Contributors to Risk and Severity of Multiple Sclerosis. Biomolecules 11 (10) (2021)
Michael Hecker, Brit Fitzner, Kathrin Jäger, Jan Bühring, Margit Schwartz, Alexander Hartmann, Michael Walter, Uwe Klaus Zettl
Leukocyte Telomere Length in Patients with Multiple Sclerosis and Its Association with Clinical Phenotypes. Molecular neurobiology 58 (6) (2021)
Paloma Gómez-Fernández, Aitzkoa Lopez de Lapuente Portilla, Ianire Astobiza, Jorge Mena, Andoni Urtasun, Vivian Altmann, Fuencisla Matesanz, David Otaegui, Elena Urcelay, Alfredo Antigüedad, Sunny Malhotra, Xavier Montalban, Tamara Castillo-Triviño, Laura Espino-Paisán, Orhan Aktas, Mathias Buttmann, Andrew Chan, Bertrand Fontaine, Pierre-Antoine Gourraud, Michael Hecker, Sabine Hoffjan, Christian Kubisch, Tania Kümpfel, Felix Luessi, Uwe K Zettl, Frauke Zipp, Iraide Alloza, Manuel Comabella, Christina M Lill, Koen Vandenbroeck
The Rare IL22RA2 Signal Peptide Coding Variant rs28385692 Decreases Secretion of IL-22BP Isoform-1, -2 and -3 and Is Associated with Risk for Multiple Sclerosis. Cells 9 (1) (2020)
Niklas Frahm, Michael Hecker, Uwe Klaus Zettl
Polypharmacy among patients with multiple sclerosis: a qualitative systematic review. Expert opinion on drug safety 19 (2) (2020)
Niklas Frahm, Michael Hecker, Uwe Klaus Zettl
Polypharmacy in patients with multiple sclerosis: a gender-specific analysis. Biology of sex differences 10 (1) (2019)
Niklas Frahm, Michael Hecker, Uwe Klaus Zettl
Polypharmacy in outpatients with relapsing-remitting multiple sclerosis: A single-center study. PloS one 14 (1) (2019)
Niklas Frahm, Michael Hecker, Uwe Klaus Zettl
Multi-drug use among patients with multiple sclerosis: A cross-sectional study of associations to clinicodemographic factors. Scientific reports 9 (1) (2019)
Michael Hecker, Nina Boxberger, Nicole Illner, Brit Fitzner, Ina Schröder, Alexander Winkelmann, Ales Dudesek, Stefanie Meister, Dirk Koczan, Peter Lorenz, Hans-Jürgen Thiesen, Uwe Klaus Zettl
A genetic variant associated with multiple sclerosis inversely affects the expression of CD58 and microRNA-548ac from the same gene. PLoS genetics 15 (2) (2019)
Nina Boxberger, Michael Hecker, Uwe K Zettl
Dysregulation of Inflammasome Priming and Activation by MicroRNAs in Human Immune-Mediated Diseases. Journal of immunology (Baltimore, Md. : 1950) 202 (8) (2019)
Ines C Angerer, Michael Hecker, Dirk Koczan, Luisa Roch, Jörg Friess, Annelen Rüge, Brit Fitzner, Nina Boxberger, Ina Schröder, Kristin Flechtner, Hans-Jürgen Thiesen, Alexander Winkelmann, Stefanie Meister, Uwe K Zettl
Transcriptome profiling of peripheral blood immune cell populations in multiple sclerosis patients before and during treatment with a sphingosine-1-phosphate receptor modulator. CNS neuroscience & therapeutics 24 (3) (2018)
Alexander Winkelmann, Paulus Stefan Rommer, Michael Hecker, Uwe Klaus Zettl
Intravenous immunoglobulin treatment in multiple sclerosis: A prospective, rater-blinded analysis of relapse rates during pregnancy and the postnatal period. CNS neuroscience & therapeutics 25 (1) (2018)
Christoph Metze, Alexander Winkelmann, Micha Loebermann, Michael Hecker, Brunhilde Schweiger, Emil Christian Reisinger, Uwe Klaus Zettl
Immunogenicity and predictors of response to a single dose trivalent seasonal influenza vaccine in multiple sclerosis patients receiving disease-modifying therapies. CNS neuroscience & therapeutics 25 (2) (2018)